Jerome D. Goldberg

Array ( [id] => 4216319 [patent_doc_number] => 06110905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Long-acting oxytetracycline composition' [patent_app_type] => 1 [patent_app_number] => 9/159680 [patent_app_country] => US [patent_app_date] => 1998-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1690 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110905.pdf [firstpage_image] =>[orig_patent_app_number] => 159680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924254 [patent_doc_number] => 05914342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => '2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists' [patent_app_type] => 1 [patent_app_number] => 9/159698 [patent_app_country] => US [patent_app_date] => 1998-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16633 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914342.pdf [firstpage_image] =>[orig_patent_app_number] => 159698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924687 [patent_doc_number] => 05945411 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Chemoprevention of metachronous adenomatous colorectal polyps' [patent_app_type] => 1 [patent_app_number] => 9/158871 [patent_app_country] => US [patent_app_date] => 1998-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6190 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945411.pdf [firstpage_image] =>[orig_patent_app_number] => 158871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190373 [patent_doc_number] => 06153610 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => '1,2,4-benzotriazine oxides formulations' [patent_app_type] => 1 [patent_app_number] => 9/157905 [patent_app_country] => US [patent_app_date] => 1998-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4715 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153610.pdf [firstpage_image] =>[orig_patent_app_number] => 157905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288516 [patent_doc_number] => 06268372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones' [patent_app_type] => 1 [patent_app_number] => 9/151665 [patent_app_country] => US [patent_app_date] => 1998-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5868 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268372.pdf [firstpage_image] =>[orig_patent_app_number] => 151665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101840 [patent_doc_number] => 06066665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Combination of cis-4-hydroxy-L-proline and N-methyl-cis-4-hydroxy-L-proline for use as a therapeutic agent, in particular in cancer treatment' [patent_app_type] => 1 [patent_app_number] => 9/142478 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 1997 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066665.pdf [firstpage_image] =>[orig_patent_app_number] => 142478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096628 [patent_doc_number] => 06096734 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Photosensitizers for sensitizing cells' [patent_app_type] => 1 [patent_app_number] => 9/139604 [patent_app_country] => US [patent_app_date] => 1998-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4792 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096734.pdf [firstpage_image] =>[orig_patent_app_number] => 139604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086801 [patent_doc_number] => 06025377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Pharmaceutical composition for inhibiting the growth of cancers' [patent_app_type] => 1 [patent_app_number] => 9/138058 [patent_app_country] => US [patent_app_date] => 1998-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2981 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025377.pdf [firstpage_image] =>[orig_patent_app_number] => 138058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297734 [patent_doc_number] => 06187315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Compositions and methods of treating cancer with tannin complexes' [patent_app_type] => 1 [patent_app_number] => 9/130458 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5985 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 426 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187315.pdf [firstpage_image] =>[orig_patent_app_number] => 130458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359385 [patent_doc_number] => 06174918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Naphthoquinone antitumor compound and method' [patent_app_type] => 1 [patent_app_number] => 9/126624 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16148 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174918.pdf [firstpage_image] =>[orig_patent_app_number] => 126624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4261606 [patent_doc_number] => 06258849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate' [patent_app_type] => 1 [patent_app_number] => 9/121567 [patent_app_country] => US [patent_app_date] => 1998-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9096 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 279 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258849.pdf [firstpage_image] =>[orig_patent_app_number] => 121567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937407 [patent_doc_number] => 05972914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Remedies for liver diseases' [patent_app_type] => 1 [patent_app_number] => 9/118866 [patent_app_country] => US [patent_app_date] => 1998-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6165 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972914.pdf [firstpage_image] =>[orig_patent_app_number] => 118866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328780 [patent_doc_number] => 06319911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Prevention of ovarian cancer by administration of progestin products' [patent_app_type] => 1 [patent_app_number] => 9/118143 [patent_app_country] => US [patent_app_date] => 1998-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11736 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319911.pdf [firstpage_image] =>[orig_patent_app_number] => 118143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067608 [patent_doc_number] => 06068839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Antibiotics TKR1912-I and TKR1912-II and process for producing the same' [patent_app_type] => 1 [patent_app_number] => 8/913250 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 4423 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/068/06068839.pdf [firstpage_image] =>[orig_patent_app_number] => 913250 [rel_patent_id] =>[rel_patent_doc_number] =>)